methylprednisolone has been researched along with Hematologic Malignancies in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 13 (54.17) | 29.6817 |
| 2010's | 7 (29.17) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Kawai, M; Kim, H; Kitamura, A; Nakamura, R; Ogawa, N; Sanada, M; Tamura, R; Tsukamoto, T; Urushitani, M; Yamakawa, I | 1 |
| Juvonen, E; Nihtinen, A; Niittyvuopio, R; Ruutu, T; Volin, L | 1 |
| Blahutová, Š; Čermáková, Z; Faber, E; Hubáček, J; Indrák, K; Kolář, M; Papajík, T; Raida, L; Rohoň, P; Szotkowski, T; Urbanová, R; Vráblová, L | 1 |
| Barratt, A; Carroll, RP; Hope, CM; Krige, AJ | 1 |
| Chen, ZC; Li, L; Li, QB; Xia, LH; You, Y; Zou, P | 1 |
| Abboud, M; Barker, JN; Hawke, R; Heller, G; Patel, KJ; Rice, RD; Scaradavou, A; Young, JW | 1 |
| Alousi, AM; Champlin, RE; Couriel, DR; Giralt, S; Okoroji, GJ; Rashid, A; Rondon, G; Saliba, RM | 1 |
| Al Jefri, A; Al Jumaah, S; Al Muhsen, S; Al Seraihi, A; Al-Hajjar, S; Ayas, M; El Solh, H; Shoukri, M | 1 |
| Ding, K; Geng, L; Li, L; Liu, H; Liu, X; Sun, Z; Tong, J; Wang, X; Zhu, W | 1 |
| Diaconescu, R; Maloney, DG; Maris, MB; McSweeney, P; Parikh, CR; Sandmaier, BM; Schrier, RW; Sorror, ML; Storb, R; Storer, B | 1 |
| Ikeda, T; Miyanishi, E; Nagaya, S; Nakase, K; Shiku, H; Tamaki, S; Tanigawa, M; Tsuji, K | 1 |
| Bambach, B; Benekli, M; Cooper, M; Hahn, T; McCarthy, PL; Roy, HN; Stewart, C; Wallace, P; Williams, BT | 1 |
| Fujioka, T; Hasei, H; Ikegame, K; Inoue, T; Kaida, K; Kawakami, M; Kawase, I; Kim, EH; Masuda, T; Ogawa, H; Taniguchi, Y; Yoshihara, S | 1 |
| Abe, Y; Imataki, O; Kawakami, K; Kusafuka, K; Tamai, Y | 1 |
| Hall, J; Melhuish, J; Rudin, CE | 1 |
| Fujioka, T; Hasei, H; Iiboshi, Y; Ikegame, K; Inoue, T; Kaida, K; Kawakami, M; Kawase, I; Kim, EH; Ogawa, H; Soma, T; Tamaki, H; Taniguchi, Y; Tazuke, Y; Yoshihara, S | 1 |
| Anasetti, C; Appelbaum, FR; Boeckh, M; Chauncey, TR; Deeg, HJ; Doney, K; Flowers, M; Leisenring, W; Lin, D; Martin, P; Nash, R; Schoch, G; Storb, R; Sullivan, KM; Witherspoon, RP | 1 |
| Alessandrino, P; Arcese, W; Bacigalupo, A; Bosi, A; Dini, G; Falda, M; Giorgiani, G; Iori, AP; Locasciulli, A; Locatelli, F; Majolino, I; Miniero, R; Rotoli, B; Scimé, R; Uderzo, C; Van Lint, MT | 1 |
| Abboud, C; Constine, L; DiPersio, J; Duerst, R; Liesveld, J; Linder, T; McKenna, B; Packman, C; Rapoport, A; Rowe, J; Silverman, W; Swift, S; Wedow, L; Zwetsch, L | 1 |
| Bonneterre, J; Harousseau, JL; Hedouin, M; Ouvry, J; Zittoun, R | 1 |
| Appelbaum, FR; Deeg, HJ; Flowers, ME; Leisenring, W; Martin, PJ; Storb, RF | 1 |
| Elonen, E; Juvonen, E; Parkkali, T; Ruutu, T; Volin, L | 1 |
| Akpek, G; Anders, V; Lee, SM; Vogelsang, GB | 1 |
| Grignard, F; Schots, R; Trullemans, F; Van Camp, B | 1 |
12 trial(s) available for methylprednisolone and Hematologic Malignancies
| Article | Year |
|---|---|
A randomized study of cyclosporine and methotrexate with or without methylprednisolone for the prevention of graft-versus-host disease: Improved long-term survival with triple prophylaxis.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Middle Aged; Transplantation, Homologous; Young Adult | 2018 |
Prognostic value of response after upfront therapy for acute GVHD.
Topics: Acute Disease; Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Incidence; Infliximab; Male; Methylprednisolone; Middle Aged; Stem Cell Transplantation; Survival Rate; Transplantation, Homologous | 2012 |
Pre-engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Anti-Inflammatory Agents; C-Reactive Protein; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Disease-Free Survival; Erythema; Female; Fever; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Incidence; Male; Methylprednisolone; Middle Aged; Neutrophils; Retrospective Studies; Risk Factors; Survival Rate; Syndrome; Time Factors; Transplantation Conditioning; Transplantation, Homologous | 2012 |
Muromonab-CD3 (Orthoclone OKT3), methylprednisolone and cyclosporine for acute graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; CD3 Complex; Child; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; T-Lymphocytes; Transplantation, Homologous | 2006 |
Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
Topics: Adult; Antilymphocyte Serum; Bone Marrow; Busulfan; CD4 Lymphocyte Count; Combined Modality Therapy; Cytokines; Disease-Free Survival; Family; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Incidence; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; T-Lymphocytes; Tacrolimus; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2006 |
Failure of the addition of methylprednisolone to intermediate-dose cyclophosphamide and lenograstim for stem cell mobilization to make the timing of PBSC harvesting more predictable.
Topics: Adjuvants, Immunologic; Cell Separation; Cyclophosphamide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Humans; Immunosuppressive Agents; Lenograstim; Male; Methylprednisolone; Peripheral Blood Stem Cell Transplantation; Recombinant Proteins; Time Factors; Transplantation, Autologous | 2007 |
Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Incidence; Living Donors; Methotrexate; Methylprednisolone; Mycophenolic Acid; Myeloablative Agonists; Postoperative Complications; Tacrolimus; Transplantation Conditioning; Whole-Body Irradiation | 2008 |
Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Infant; Infections; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Recurrence; Respiratory Insufficiency; Transplantation Conditioning; Treatment Outcome | 1997 |
Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; Humans; Hyperglycemia; Hypertension; Immunosuppressive Agents; Infant; Infections; Italy; Male; Methylprednisolone; Middle Aged; Nuclear Family; Prospective Studies; Recurrence; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 1998 |
[Improvement in the control of chemotherapy induced emesis with ondansetron, methylprednisolone and lorazepam combination in patients treated by a moderate emetic treatment and uncontrolled by a previous antiemetic combination].
Topics: Adult; Antiemetics; Breast Neoplasms; Double-Blind Method; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Lorazepam; Male; Methylprednisolone; Middle Aged; Nausea; Ondansetron; Patient Satisfaction; Quality of Life; Vomiting | 2000 |
Cyclosporine (CSP)or CSP plus methylprednisolone for graft-versus-host disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: long-term follow-up of a randomized trial.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Glucocorticoids; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Methylprednisolone; Middle Aged; Time Factors | 2000 |
Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study.
Topics: Acute Disease; Adolescent; Adult; Blood Transfusion; Bone and Bones; Bone Marrow Transplantation; Cause of Death; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility Testing; Hospitalization; Humans; Infections; Male; Methotrexate; Methylprednisolone; Middle Aged; Necrosis; Nuclear Family; Prospective Studies; Recurrence; Survival Rate | 2000 |
12 other study(ies) available for methylprednisolone and Hematologic Malignancies
| Article | Year |
|---|---|
The Effect of Intravenous Methylprednisolone on Recurrent Exacerbation in Hematologic Malignancy-associated Progressive Multifocal Leukoencephalopathy.
Topics: Aged; Contrast Media; Gadolinium; Hematologic Neoplasms; Humans; Immune Reconstitution Inflammatory Syndrome; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Methylprednisolone | 2021 |
Granulocyte transfusions collected after steroid priming for severe infections during neutropenia: A single center experience.
Topics: Adult; Aged; Anti-Infective Agents; Blood Component Removal; Blood Component Transfusion; Febrile Neutropenia; Female; Granulocytes; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyethyl Starch Derivatives; Male; Methylprednisolone; Middle Aged; Mycoses; Pneumonia; Retrospective Studies; Sepsis; Soft Tissue Infections; Young Adult | 2019 |
Reductions in immunosuppression after haematological or solid organ cancer diagnosis in kidney transplant recipients.
Topics: Adolescent; Adult; Aged; Australia; Cohort Studies; Creatinine; Databases, Factual; Disease-Free Survival; Female; Graft Rejection; Graft Survival; Hematologic Neoplasms; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; New Zealand; Recurrence; Renal Insufficiency; Time Factors; Treatment Outcome; Young Adult | 2015 |
A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Aspergillus; Busulfan; China; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Idarubicin; Immunosuppressive Agents; Leukemia; Leukemia, Myeloid, Acute; Male; Methylprednisolone; Mucositis; Pneumonia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Premedication; Retrospective Studies; Risk Factors; Semustine; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2009 |
Pre-engraftment syndrome after double-unit cord blood transplantation: a distinct syndrome not associated with acute graft-versus-host disease.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Exanthema; Female; Fever of Unknown Origin; Graft Rejection; Graft vs Host Disease; Hematologic Neoplasms; Humans; Kaplan-Meier Estimate; Leukocyte Count; Male; Methylprednisolone; Middle Aged; Neutrophils; Postoperative Complications; Retrospective Studies; Syndrome; Transplantation Conditioning; Treatment Outcome; Young Adult | 2010 |
Cytomegalovirus infections in unrelated cord blood transplantation in pediatric patients: incidence, risk factors, and outcomes.
Topics: Age Factors; Anti-Inflammatory Agents; Antibodies, Viral; Case-Control Studies; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Incidence; Infant; Male; Methylprednisolone; Phosphoproteins; Retrospective Studies; Risk Factors; Transplantation, Homologous; Treatment Outcome; Viral Matrix Proteins; Virus Activation | 2011 |
Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Busulfan; Cohort Studies; Comorbidity; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Methylprednisolone; Middle Aged; Mycophenolic Acid; Patient Selection; Postoperative Complications; Recurrence; Renal Dialysis; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2005 |
Acute interstitial pneumonitis during chemotherapy for haematological malignancy.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Leukocyte Count; Lung; Lung Diseases, Interstitial; Male; Methylprednisolone; Middle Aged; Radiography; Treatment Outcome | 2005 |
[Three cases of necrotizing pneumonia by pseudomonas aeruginosa infection in hematological malignancy, including dead and alive cases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Fatal Outcome; Hematologic Neoplasms; Humans; Male; Methotrexate; Methylprednisolone; Middle Aged; Necrosis; Neutropenia; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Severity of Illness Index | 2007 |
Continuous infusion cyclosporine and nifedipine to day +100 with short methotrexate and steroids as GVHD prophylaxis in unrelated donor transplants.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Calcium Channel Blockers; Cause of Death; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Infant; Life Tables; Male; Methotrexate; Methylprednisolone; Middle Aged; Nifedipine; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Wiskott-Aldrich Syndrome | 1999 |
A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Chronic Disease; Disease Progression; Drug Administration Schedule; Drug Evaluation; Female; Follow-Up Studies; Genetic Diseases, Inborn; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Infection Control; Life Tables; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome | 2001 |
Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Brain; Brain Edema; Cerebellum; Cerebral Cortex; Child; Child, Preschool; Cholesterol; Cyclosporine; Drug Synergism; Female; Follow-Up Studies; Headache; Hematologic Neoplasms; Humans; Hypertension; Immunosuppressive Agents; Infant; Magnesium; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Nervous System Diseases; Paresis; Seizures; T-Lymphocytes; Transplantation, Homologous; Vision Disorders | 2001 |